Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the Memorial Sloan-Kettering (T12) protocol

Journal of Clinical Oncology

Volumn 16, Issue 7, 1998, Pages 2452-2458

  Meyers, Paul A ^a   Gorlick, Richard ^b   Heller, Glenn ^b   Casper, Ephraim ^b   Lane, Joseph ^b   Huvos, Andrew G ^b   Healey, John H ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PREOPERATIVE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR NECROSIS;

EID: 0031861214     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.7.2452     Document Type: Article

References (20)

1. Dahlin DC, Coventry MB: Osteogenic sarcoma. A study of six hundred cases. J Bone Joint Surg 49:101-110, 1967
2. Marcove RC, Mike V, Hajek JV, et al: Osteogenic sarcoma under the age of twenty-one: A review of one hundred forty-rive operative cases. J Bone Joint Surg 52:411-423, 1970
3. Harvei S, Solheim O: The prognosis in osteosarcoma: Norwegian national data. Cancer 48:1719-1723, 1981
4. Link MP, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600-1606, 1986
5. Eilber F, Giulano A, Eckardt J, et al: Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial. J Clin Oncol 5:21-26, 1987
6. Rosen G, Murphy ML, Huvos AG, et al: Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37:1-11, 1976
7. Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163-2177, 1979
8. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221-1230, 1982
9. Winkler K, Beron G, Delling G, et al: Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329-337, 1988
10. Saeter G, Alvegard TA, Elomaa I, et al: Treatment of osteosarcoma of the extremities with the T-10 protocol with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group study. J Clin Oncol 9:1766-1775, 1991
11. Meyers PA, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan Kettering experience. J Clin Oncol 10:5-15, 1992
12. Provisor AJ, Ettinger LJ, Nachman JB, et al: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group. J Clin Oncol 15:76-84, 1997
13. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley-Liss, 1980
14. Bacci G, Mercuri M, Bricolli A, et al: Osteogenic sarcoma of the extremity with detectable lung metastases at presentation: Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer 79:245-254, 1997
15. Meyers PA, Heller G, Healey JH, et al: Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11:449-453, 1993
16. Taylor WF, Ivins JC, Unni KK, et al: Prognostic variables in osteosarcoma: A multi-institutional study. J Natl Cancer Inst 81:21-30, 1989
17. Damron TA, Pritchard DJ: Current combined treatment of high-grade osteosarcomas. Oncology 9:327-350, 1995
18. Meyers PA, Gorlick R: Osteosarcoma. Pediatr Clin North Am 44:973-990, 1997
19. Goorin A, Baker A, Gieser P, et al: No evidence for improved event free survival (EFS) with presurgical chemotherapy (PRE) for non-metastatic extremity osteogenic sarcoma: Preliminary results of randomized Pediatric Oncology Group (POG) trial 8651. Proc Am Soc Clin Oncol 14:444, 1995 (abstr)
20. Glasser DB, Lane JM, Huvos AG, et al: Survival, prognosis and therapeutic response in osteogenic sarcoma. Cancer 69:698-708, 1992